• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sarah Faulkner

Senseonics touts BCBS reimbursement wins

September 4, 2019 By Sarah Faulkner

Senseonics - updated logo

Senseonics (NYSE:SENS) said today that Blue Cross Blue Shield of Massachusetts and Idaho now provide coverage for the implantable Eversense continuous glucose monitor. The company’s Eversense device includes a fluorescence-based sensor, a mobile app and a transmitter. Senseonics’ touts its system as being the first with a long-term, implantable CGM sensor, as well as the first […]

Filed Under: Business/Financial News, Diabetes, Featured, mHealth (Mobile Health), Wall Street Beat Tagged With: Senseonics

Insulet prices $700m offering

September 4, 2019 By Sarah Faulkner

Insulet's Omnipod Dash system

Insulet (NSDQ:PODD) today priced a private placement of $700 million in convertible senior notes due 2026. The offering is slated to close on Sept. 6. The Acton, Mass.-based company said in a press release it also gave initial purchasers an option to buy up to an additional $100 million in notes. Insulet reported that it expects […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Wall Street Beat Tagged With: Insulet

Insulet touts full market launch of mobile apps for Omnipod Dash

August 9, 2019 By Sarah Faulkner

Insulet's Omnipod Dash system

Insulet (NSDQ:PODD) touted the full market launch of the Omnipod Display and Omnipod View apps for people using the company’s Omnipod Dash system. The Display app enables users to display data from their Personal Diabetes Manager device onto their smartphones. The View app gives caregivers and family members the option to remotely monitor Omnipod Dash […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Wall Street Beat Tagged With: Insulet

On mixed Q2 results, Glaukos announces Avedro buy

August 8, 2019 By Sarah Faulkner

Glaukos logo

Glaukos (NYSE:GKOS) posted its second-quarter financial results this week and reported that it plans to acquire Avedro in an effort to build out its corneal health franchise. Avedro develops single-use drug formulations designed to strengthen corneal tissue and stop the progression of a degenerative corneal ectatic disease known as keratoconus. According to the Mass.-based company, the […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Optical/Ophthalmic, Pharmaceuticals, Wall Street Beat Tagged With: Avedro Inc., Glaukos

Avoset to develop infusion pump with unnamed pharma giant

July 12, 2019 By Sarah Faulkner

Avoset Health said this week that it plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021. The company touted that its technology allows physicians and pharmacists to track when patients receive infusions, how much drug was infused and which patients need additional intervention. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: avosethealth

NovaBay raises $2.4m

July 5, 2019 By Sarah Faulkner

NovaBay Pharmaceuticals (NYSE:NBY) said this week that it raised $2.4 million in an offering that included three investors. The Emeryville, Calif.-based company has developed products for the eye care market, including a prescription for managing hygiene of the eyelids and lashes. NovaBay’s Avenova is formulated with a pure form of hypochlorous acid and is designed to […]

Filed Under: Featured, Funding Roundup, Optical/Ophthalmic Tagged With: novabay

Inside Insulet’s pivotal year with CEO Shacey Petrovic

June 20, 2019 By Sarah Faulkner

DeviceTalks Boston 2019 - Shacey Petrovic Interview

It’s been a busy year at Insulet (NSDQ:PODD). The diabetes tech company welcomed a new CEO, launched its first new product in six years and officially opened its $200 million global headquarters – all in the first half of 2019. That’s all the result of years of rapid growth for Insulet, chief executive Shacey Petrovic said in a keynote […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Insulet

Mercator MedSystems adds $3m

June 17, 2019 By Sarah Faulkner

Mercator MedSystems updated logo

Mercator MedSystems said last week that it added more than $3 million to the $11 million Series D it pulled in last year.* The California-based company is developing catheter-guided micro-infusion systems for non-systemic delivery of therapeutic agents across blood vessels as a treatment for peripheral artery disease. In June of last year, Mercator MedSystems raised […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Vascular Tagged With: Mercator MedSystems

Dance Biopharm raises $21m for insulin delivery device

June 11, 2019 By Sarah Faulkner

Dance Biopharm

Dance Biopharm has raised $21 million from 283 investors as part of a $59.2 million offering, according to a document filed with the SEC this week. The privately-held California-based company’s Dance 501 device stores a liquid formulation of recombinant human insulin in a hand-held electronic inhaler. Using a vibrating mesh, the device produces particles of liquid […]

Filed Under: Diabetes, Featured, Funding Roundup, Pharmaceuticals Tagged With: dancebiopharm

Ivenix wins 510(k) clearance for infusion system

June 11, 2019 By Sarah Faulkner

Ivenix logo

Ivenix said today that its infusion system won 510(k) clearance from the FDA. The large-volume pump and infusion system features a “smartphone-like” user interface and a suite of administration tools to remotely monitor infusions, according to Ivenix. The Boston-based company reported that infusion-related adverse drug events make up more than $2 million in healthcare costs […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Hospital Care, Pharmaceuticals, Regulatory/Compliance Tagged With: Ivenix

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 241
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS